BCL2 is known to maintain mitochondrial membrane integrity and crosstalk with pathways like angiogenesis and MAPK pathway; therefore, when Disarib disrupts BCL2, mitochondrial processes and its other crosstalk pathway get affected and contribute towards tumour reduction. Here, BCL2 is linked to neoplasm.